Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Modified-release tablet: 30 mg
Registered products in the Philippines
1 product registered with the Food and Drug Administration (FDA) Philippines list Gly4par mr-30 as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
GliclazideGLY4PAR MR-30 | 30 mg Modified-Release TabletAlu-PVC/PVDC Blister Pack x 10's (Box of 30's) | Rx | Inventia Healthcare LimitedIndia | Metro Drug, Inc.Importer: Mega Lifesciences (Australia) Pty. Ltd.Trader: Mega Lifesciences Limited Inc. | DR-XY49454 | Jul 18, 2030 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .